We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEN
2626
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$0 ﹤0.01%
12
PHAS
2627
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-5,000
Closed -$20
RDUS
2628
DELISTED
Radius Health, Inc.
RDUS
$0 ﹤0.01%
18
-1,100
-98% -$26.7K
NPTN
2629
DELISTED
NEOPHOTONICS CORP
NPTN
-24,329
Closed -$148
MIC
2630
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
-5
Closed
COHR
2631
DELISTED
Coherent Inc
COHR
$0 ﹤0.01%
6
APTS
2632
DELISTED
Preferred Apartment Communities, Inc.
APTS
$0 ﹤0.01%
54
SFUN
2633
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$0 ﹤0.01%
20
SRGA
2634
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$0 ﹤0.01%
5
HGH
2635
DELISTED
THE HARTFORD FINANCIAL SERVICES GROUP, INC. 7.875% FIXED-TO-FLOATING RATE JR SUB DEBENTURE DUE 2042
HGH
$0 ﹤0.01%
12
RVI
2636
DELISTED
Retail Value Inc. Common Shares
RVI
$0 ﹤0.01%
54
-2,299
-98% -$7.7K
RRD
2637
DELISTED
RR Donnelley & Sons Co.
RRD
$0 ﹤0.01%
65
NNA
2638
DELISTED
Navios Maritime Acquisition Corporation
NNA
$0 ﹤0.01%
33
PFPT
2639
DELISTED
Proofpoint, Inc.
PFPT
$0 ﹤0.01%
5
BPY
2640
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$0 ﹤0.01%
5
-8,895
-100% -$168K
GLOG
2641
DELISTED
GASLOG LTD
GLOG
-1,250
Closed -$16
APHA
2642
DELISTED
Aphria Inc. Common Shares
APHA
-200
Closed -$1
GNMK
2643
DELISTED
GenMark Diagnostics, Inc
GNMK
$0 ﹤0.01%
24
-1,000
-98% -$5.52K
DL
2644
DELISTED
China Distance Education Holdings Limited
DL
$0 ﹤0.01%
97
WRB.PRC
2645
DELISTED
W.R. Berkley Corporation 5.900% Subordinated Debentures due 2056
WRB.PRC
$0 ﹤0.01%
7
CLCT
2646
DELISTED
Collectors Universe
CLCT
-30
Closed
AIG.WS
2647
DELISTED
American International Group, Inc.
AIG.WS
$0 ﹤0.01%
+21
New +$249
VER
2648
DELISTED
VEREIT, Inc.
VER
-11,676
Closed -$570
HUD
2649
DELISTED
Hudson Ltd. Class A Common Shares
HUD
-700
Closed -$8
MLPI
2650
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
-18,874
Closed -$393

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.